Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Evaluating a polypill for managing coronary risk factors

Official title: Cross-over Analysis of the Control of Coronary Risk Factors and Level of Platelet Inhibition With a Polypill

Run by Fundación EPIC · NCT05030818 · Data updated 2026-11-12

This study tests if a combined pill with three heart medications can help people with coronary artery disease manage their blood pressure and cholesterol better than taking the medications separately.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment88 (estimated)
SponsorFundación EPIC
Academic / other
Locations1 site (Gijón, Principality of Asturias)
StatusRecruiting
StartedOctober 14, 2022
Main results expectedMarch 30, 2026
Study endsApril 30, 2026
Registry record updatedAugust 5, 2025
Trial IDNCT05030818 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old currently using the Trinomia® polypill for secondary prevention of cardiovascular disease.

Probably not a fit

Patients with contraindications to any component of the polypill or those with life expectancy limitations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label, randomized, cross-over study investigates the effectiveness of a polypill containing acetylsalicylic acid, ramipril, and atorvastatin in patients with coronary artery disease. Participants will alternate between taking the polypill and the individual components over a six-month period, with the primary focus on measuring systolic blood pressure and LDL cholesterol levels. The study aims to determine if the polypill improves adherence and health outcomes compared to taking the medications separately. Monthly follow-up visits will ensure proper monitoring and data collection.

Why it matters

Potential benefit: If successful, this study could enhance treatment adherence and improve cardiovascular health outcomes for patients with coronary artery disease.

How similar studies have gone: While there have been successful studies on polypills for cardiovascular prevention, this specific cross-over design comparing the polypill to its individual components is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients over 18 years of age. Patients under treatment with the Trinomia® polypill in any of its presentations for indication of secondary prevention and who can make the 6 visits necessary to complete the study. Patients who sign the Informed Consent.

Exclusion Criteria:

Patients who do not sign the informed consent. Patients with an inability to understand and comply with the protocol. Patients with contraindication to any component of the polypill. Patients who are already participating in another clinical trial. Patients with any condition that limits life expectancy to \<1 year. Patients with programmed coronary revascularization. Patients with coronary stent implantation in the last 12 months. Patients treated with any antithrombotic drug in addition to acetylsalicylic acid, that is, low molecular weight heparin, P2Y12 receptor inhibitors, or oral anticoagulants.

Where it's running

  • Hospital Universitario de Cabueñes
    Gijón, Principality of Asturias, Spain
    Recruiting

Study contacts

  • Principal investigator: Iñigo Lozano, MD, PHD — Hospital de Cabueñes, Gijon
  • Study coordinator: Iñigo Lozano Martinez-Luengas, MD, PHD
  • Email: inigo.lozano@gmail.com
  • Phone: +34630901145

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.